InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
HEK-Blue™ mNOD2 | Recombinant Attenuated Edwardsiella piscicida Vaccine Displaying Regulated Ly... | 2023 | Vaccines (Basel). | Swain B. et al. | DOI: 10.3390/vaccines11091470 |
Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Recombinant Attenuated Edwardsiella piscicida Vaccine Displaying Regulated Ly... | 2023 | Vaccines (Basel). | Swain B. et al. | DOI: 10.3390/vaccines11091470 |
HEK-Blue™ mNOD1 | Recombinant Attenuated Edwardsiella piscicida Vaccine Displaying Regulated Ly... | 2023 | Vaccines (Basel). | Swain B. et al. | DOI: 10.3390/vaccines11091470 |
LPS-EB VacciGrade™ | Micro-lightguide spectrophotometry assessment of hepatic and intestinal micro... | 2023 | Eur J Pharm Sci. | Schmidt G. et al. | DOI: 10.1016/j.ejps.2023.106588 |
Poly(I:C) HMW | Biodistribution of mRNA COVID-19 vaccines in human breast milk. | 2023 | EBioMedicine | Hanna N. et al. | DOI: 10.1016/j.ebiom.2023.104800 |
R848 (Resiquimod) | Biodistribution of mRNA COVID-19 vaccines in human breast milk. | 2023 | EBioMedicine | Hanna N. et al. | DOI: 10.1016/j.ebiom.2023.104800 |
Primocin® | Clonal evolution of long-term expanding head and neck cancer organoid: Impact... | 2023 | Oral Oncol. | Choi S.Y. et al. | DOI: 10.1016/j.oraloncology.2023.106571 |
NLRP3 inflammasome inhibitor - MCC950 | NLRP3 selectively drives IL-1β secretion by Pseudomonas aeruginosa infected n... | 2023 | Nat Commun. | Minns M.S. et al. | DOI: 10.1038/s41467-023-41391-7 |
IL-1α & IL-1β Reporter HEK 293 Cells | NLRP3 selectively drives IL-1β secretion by Pseudomonas aeruginosa infected n... | 2023 | Nat Commun. | Minns M.S. et al. | DOI: 10.1038/s41467-023-41391-7 |
QUANTI-Blue™ | NLRP3 selectively drives IL-1β secretion by Pseudomonas aeruginosa infected n... | 2023 | Nat Commun. | Minns M.S. et al. | DOI: 10.1038/s41467-023-41391-7 |
Blasticidin | Combined inhibition of Bcl-2 family members and YAP induces synthetic lethali... | 2023 | Mol Cancer | Kwon J.W. et al. | DOI: 10.1186/s12943-023-01857-0 |
Puromycin | Combined inhibition of Bcl-2 family members and YAP induces synthetic lethali... | 2023 | Mol Cancer | Kwon J.W. et al. | DOI: 10.1186/s12943-023-01857-0 |
Normocin® - Antimicrobial Reagent | Applications of Human Pluripotent Stem Cell-Derived Skin Organoids in Dermato... | 2023 | J Invest Dermatol. | Sandoval A.G.W. et al. | DOI: 10.1016/j.jid.2023.07.017 |
LPS-EB (LPS from E. coli O111:B4) | Metabolic Reprogramming via ACOD1 depletion enhances function of human induce... | 2023 | Nat Commun. | Wang X. et al. | DOI: 10.1038/s41467-023-41470-9 |
pDRIVE-Fibronectin | RNA-binding protein-regulated fibronectin is essential for EGFR-activated met... | 2023 | FASEB J. | Shieh J.M. et al. | DOI: 10.1096/fj.202300527R |
R848 (Resiquimod) | Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease... | 2023 | J Immunol. | Pellerin A. et al. | DOI: 10.4049/jimmunol.2300298 |
3p-hpRNA - RIG-I agonist | Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine mo... | 2023 | Nat Commun. | Ullah T.R. et al. | DOI: 10.1038/s41467-023-41381-9 |
MycoStrip® - Mycoplasma Detection Kit | Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine mo... | 2023 | Nat Commun. | Ullah T.R. et al. | DOI: 10.1038/s41467-023-41381-9 |
Blasticidin | Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine mo... | 2023 | Nat Commun. | Ullah T.R. et al. | DOI: 10.1038/s41467-023-41381-9 |
Human TLR3 Reporter HEK293 Cells (NF-κB) | Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine mo... | 2023 | Nat Commun. | Ullah T.R. et al. | DOI: 10.1038/s41467-023-41381-9 |